Le Lézard
Subjects: Conference, Event

Variations to Marketing Authorisations - 2 Day Course (London, United Kingdom - October 8-9, 2020) - ResearchAndMarkets.com


The "Variations to Marketing Authorisations" conference has been added to ResearchAndMarkets.com's offering.

It is a key post-marketing responsibility of the marketing authorisation holder (MAH) to keep dossiers up to date, and changes must be submitted as variations to the appropriate regulatory authority.

This interactive event will provide an invaluable overview of the EU system for variations, with practical advice on the preparation and submission of various applications using the various European procedures. The course will cover the latest variation regulations and offer guidance from an industry expert on how to optimise your regulatory procedures to help achieve faster approval. The programme will include filing tips and strategies with information and advice on creating a global dossier and implementation periods.

Practical sessions throughout the two days will provide an opportunity to discuss different scenarios and strategies with other participants.

Benefits of attending:

Agenda:

Day one

Basis of EU Regulations 1234/2008 and 712/2012

Special topics in variations

Practical session: Analysing and classifying the different changes Grouping and work-sharing

Understanding Module 3

Practical session: Understanding reviewers Filing strategy

Practical session: Plan the timelines/project management of a variation submission

Day two

Other procedures

Filing tips

Submission planning

Data requirements for type II variations

Practical session: Data requirements for more complex changes Variations through national procedures and differences from centralised procedure

Mutual recognition and decentralised procedures for variations

Practical session: A variation to an example MRP authorised product including planning timelines and impact of referrals Advanced compliance

Speakers:

Andrew Willis

Consultant

Independent

Andrew Willis is an independent consultant providing expert advice and training on global regulatory solutions and pharmaceutical development. Previously, he worked for Catalent Pharma Solutions as VP Regulatory Affairs & Consulting Services. Catalent is the world's leading contract manufacturer and distributor of pharmaceuticals, and he was head of a team of internal and external regulatory affairs consultants. He qualified as a Chemist from the University of Glamorgan, after which he furthered his understanding of pharmaceutical development, working as a research chemist with Parke Davis. He has 10 years manufacturing and analytical experience prior to entering regulatory affairs as a Senior Executive Officer with responsibility for submission of European MAAs and project management of development programs. He currently has a total of 28 years pharmaceutical experience with extensive knowledge in the development and manufacture of sterile, solid oral, inhalation, topical and biotech pharmaceutical products. These experiences have allowed knowledge of many Biotech products requirements with experiences of growth hormones and multiple cancer treatments, including development and clinical registration of the first genetically modified live bacterium for such treatment. He has extensive experience of major European and US regulatory projects, in the clinical and marketing authorisation stages, and has significant experience in coordinating and managing meetings with European and US Health Authorities. Specific experience includes the project management of a large MAA requiring full clinical data, followed by Mutual Recognition of the application in all of the European Concerned Member States. The project recorded successful outcomes in all major markets (26 countries) and was viewed as highly successful by the client, meeting very stringent project timings.

For more information about this conference visit https://www.researchandmarkets.com/r/hm4rjn



News published on and distributed by: